Basic Information
| RNALocate ID: | RLID:11002966 |
| RNA Symbol: | hsa-miR-146b-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-146b-5p |
| RNA ID: | miRBase:MIMAT0002809 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23539611 |
| Tissue/Cell Line: | Seminal plasma |
| Method: | Microarray |
| Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002323 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:01002324 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01002325 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
| RLID:11002960 | Exosome | Human milk | 28688106 |
| RLID:11002961 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11002962 | Exosome | Brain tissue | 23382797 |
| RLID:11002963 | Exosome | Plasma | 23663360 |
| RLID:11002964 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11002965 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11002967 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000151 | Exosome | B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000478 | Microvesicle | Breast cell line|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-146b-5p | Diffuse large b cell lymphoma | MNDR-E-MI-15576 |
| MNDR | hsa-miR-146b-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-15577 |
| MNDR | hsa-miR-146b-5p | Oral squamous cell carcinoma | MNDR-E-MI-15578 |
| MNDR | hsa-miR-146b-5p | Medulloblastoma | MNDR-E-MI-15579 |
| MNDR | hsa-miR-146b-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-15580 |
| MNDR | hsa-miR-146b-5p | Lymphoma | MNDR-E-MI-15581 |
| MNDR | hsa-miR-146b-5p | Cutaneous t cell lymphoma | MNDR-E-MI-15582 |
| MNDR | hsa-miR-146b-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-15583 |
| MNDR | hsa-miR-146b-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-15584 |
| MNDR | hsa-miR-146b-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-15585 |
| MNDR | hsa-miR-146b-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-15586 |
| MNDR | hsa-miR-146b-5p | Her2-receptor positive breast cancer | MNDR-E-MI-15587 |
| MNDR | hsa-miR-146b-5p | Triple negative sporadic breast cancer | MNDR-E-MI-15588 |
| MNDR | hsa-miR-146b-5p | Breast cancer luminal | MNDR-E-MI-15589 |
| MNDR | hsa-miR-146b-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-15590 |
| MNDR | hsa-miR-146b-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-15591 |
| MNDR | hsa-miR-146b-5p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-15592 |
| MNDR | hsa-miR-146b-5p | Dermatomyositis | MNDR-E-MI-15593 |
| MNDR | hsa-miR-146b-5p | Prostate cancer | MNDR-E-MI-15594 |
| MNDR | hsa-miR-146b-5p | Hormone-refractory prostate carcinoma | MNDR-E-MI-15595 |
| MNDR | hsa-miR-146b-5p | Hirschsprung disease | MNDR-E-MI-15596 |
| MNDR | hsa-miR-146b-5p | Gastric cancer | MNDR-E-MI-15597 |
| MNDR | hsa-miR-146b-5p | Alzheimer disease | MNDR-E-MI-15598 |
| MNDR | hsa-miR-146b-5p | Intracranial aneurysm | MNDR-E-MI-15599 |
| MNDR | hsa-miR-146b-5p | Esophageal carcinoma | MNDR-E-MI-15600 |
| MNDR | hsa-miR-146b-5p | Dysautonomia familial | MNDR-E-MI-15601 |
| MNDR | hsa-miR-146b-5p | Myotonic dystrophy | MNDR-E-MI-15602 |
| MNDR | hsa-miR-146b-5p | Muscular dystrophy duchenne | MNDR-E-MI-15603 |
| MNDR | hsa-miR-146b-5p | Facioscapulohumeral muscular dystrophy | MNDR-E-MI-15604 |
| MNDR | hsa-miR-146b-5p | Leukemia | MNDR-E-MI-15605 |
| MNDR | hsa-miR-146b-5p | Huntington disease | MNDR-E-MI-15606 |
| MNDR | hsa-miR-146b-5p | Chorea | MNDR-E-MI-15607 |
| MNDR | hsa-miR-146b-5p | Cardiovascular disease | MNDR-E-MI-15608 |
| MNDR | hsa-miR-146b-5p | Brain cancer | MNDR-E-MI-15609 |
| MNDR | hsa-miR-146b-5p | Lung cancer | MNDR-E-MI-15610 |
| MNDR | hsa-miR-146b-5p | Temporal arteritis | MNDR-E-MI-15611 |
| MNDR | hsa-miR-146b-5p | Fragile x syndrome | MNDR-E-MI-15612 |
| MNDR | hsa-miR-146b-5p | Parkinson disease | MNDR-E-MI-15613 |
| MNDR | hsa-miR-146b-5p | Basal-like breast cancer | MNDR-E-MI-15614 |
| MNDR | hsa-miR-146b-5p | Thyroid neoplasms | MNDR-E-MI-15615 |
| MNDR | hsa-miR-146b-5p | Pancreatic cancer | MNDR-E-MI-15616 |
| MNDR | hsa-miR-146b-5p | Melanoma | MNDR-E-MI-15617 |
| MNDR | hsa-miR-146b-5p | Rectum adenocarcinoma | MNDR-E-MI-15618 |
| MNDR | hsa-miR-146b-5p | Nephroblastoma | MNDR-E-MI-15619 |
| MNDR | hsa-miR-146b-5p | Colon cancer | MNDR-E-MI-15620 |
| MNDR | hsa-miR-146b-5p | Ischemic attack transient | MNDR-E-MI-15621 |
| MNDR | hsa-miR-146b-5p | Colon adenocarcinoma | MNDR-E-MI-15622 |
| MNDR | hsa-miR-146b-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-15623 |
| MNDR | hsa-miR-146b-5p | Familial ovarian cancer | MNDR-E-MI-15624 |
| MNDR | hsa-miR-146b-5p | Prostate adenocarcinoma | MNDR-E-MI-15625 |
| MNDR | hsa-miR-146b-5p | Carcinoma ductal breast | MNDR-E-MI-15626 |
| MNDR | hsa-miR-146b-5p | Glioblastoma | MNDR-E-MI-15627 |
| MNDR | hsa-miR-146b-5p | Astrocytoma | MNDR-E-MI-15628 |
| MNDR | hsa-miR-146b-5p | Glioma | MNDR-E-MI-15629 |
| MNDR | hsa-miR-146b-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-15630 |
| MNDR | hsa-miR-146b-5p | Nemaline myopathy | MNDR-E-MI-15631 |
| MNDR | hsa-miR-146b-5p | Central nervous system lymphoma | MNDR-E-MI-15632 |
| MNDR | hsa-miR-146b-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-15633 |
| MNDR | hsa-miR-146b-5p | Osteosarcoma | MNDR-E-MI-15634 |
| MNDR | hsa-miR-146b-5p | Inclusion body myositis | MNDR-E-MI-15635 |
| MNDR | hsa-miR-146b-5p | Meningioma | MNDR-E-MI-15636 |
| MNDR | hsa-miR-146b-5p | Cervical adenocarcinoma | MNDR-E-MI-15637 |
| MNDR | hsa-miR-146b-5p | Gastric adenocarcinoma | MNDR-E-MI-15638 |
| MNDR | hsa-miR-146b-5p | Lung squamous cell carcinoma | MNDR-E-MI-15639 |
| MNDR | hsa-miR-146b-5p | Non-small cell lung cancer | MNDR-E-MI-15640 |
| MNDR | hsa-miR-146b-5p | Thyroid carcinoma | MNDR-E-MI-15641 |
| MNDR | hsa-miR-146b-5p | Papillary thyroid carcinoma | MNDR-E-MI-15642 |
| MNDR | hsa-miR-146b-5p | Bladder urothelial carcinoma | MNDR-E-MI-15643 |
| MNDR | hsa-miR-146b-5p | Pancreatic adenocarcinoma | MNDR-E-MI-15644 |
| MNDR | hsa-miR-146b-5p | Carcinoma renal cell | MNDR-E-MI-15645 |
| MNDR | hsa-miR-146b-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-15646 |
| MNDR | hsa-miR-146b-5p | Renal clear cell carcinoma | MNDR-E-MI-15647 |
| MNDR | hsa-miR-146b-5p | Cholangiocarcinoma | MNDR-E-MI-15648 |
| MNDR | hsa-miR-146b-5p | Gallbladder carcinoma | MNDR-E-MI-15649 |
| MNDR | hsa-miR-146b-5p | Myelofibrosis | MNDR-E-MI-15650 |
| MNDR | hsa-miR-146b-5p | Esophageal cancer | MNDR-E-MI-15651 |
| MNDR | hsa-miR-146b-5p | Oncocytoma | MNDR-E-MI-15652 |
| MNDR | hsa-miR-146b-5p | Lung small cell carcinoma | MNDR-E-MI-15653 |
| MNDR | hsa-miR-146b-5p | Stomach carcinoma | MNDR-E-MI-15654 |
| MNDR | hsa-miR-146b-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-15655 |
| MNDR | hsa-miR-146b-5p | T acute lymphoblastic leukemia | MNDR-E-MI-15656 |
| MNDR | hsa-miR-146b-5p | Acute t cell leukemia | MNDR-E-MI-15657 |
| MNDR | hsa-miR-146b-5p | Adenoma | MNDR-E-MI-15658 |
| MNDR | hsa-miR-146b-5p | Breast invasive carcinoma | MNDR-E-MI-15659 |
| MNDR | hsa-miR-146b-5p | Hepatocellular carcinoma | MNDR-E-MI-15660 |
| MNDR | hsa-miR-146b-5p | Familiar ovarian carcinoma | MNDR-E-MI-15661 |
| MNDR | hsa-miR-146b-5p | Rheumatoid arthritis | MNDR-E-MI-15662 |
| MNDR | hsa-miR-146b-5p | Malignant pleural mesothelioma | MNDR-E-MI-15663 |
| MNDR | hsa-miR-146b-5p | Retinoblastoma | MNDR-E-MI-15664 |
| MNDR | hsa-miR-146b-5p | Hodgkin lymphoma | MNDR-E-MI-15665 |
| MNDR | hsa-miR-146b-5p | Burkitt lymphoma | MNDR-E-MI-15666 |
| MNDR | hsa-miR-146b-5p | Tonsil cancer | MNDR-E-MI-15667 |
| MNDR | hsa-miR-146b-5p | Neuromyelitis optica | MNDR-E-MI-15668 |
| MNDR | hsa-miR-146b-5p | Psoriasis | MNDR-E-MI-15669 |
| MNDR | hsa-miR-146b-5p | Acute myelocytic leukemia | MNDR-E-MI-15670 |
| MNDR | hsa-miR-146b-5p | Colorectal cancer | MNDR-E-MI-15671 |
| MNDR | hsa-miR-146b-5p | Nasopharynx carcinoma | MNDR-E-MI-15672 |
| MNDR | hsa-miR-146b-5p | Multiple myeloma | MNDR-E-MI-15673 |
| MNDR | hsa-miR-146b-5p | Ependymoma | MNDR-E-MI-15674 |
| MNDR | hsa-miR-146b-5p | Nasopharyngeal cancer | MNDR-E-MI-15675 |
| MNDR | hsa-miR-146b-5p | Wounds and injuries | MNDR-E-MI-15676 |
| MNDR | hsa-miR-146b-5p | Polymyositis | MNDR-E-MI-15677 |
| MNDR | hsa-miR-146b-5p | Neoplasm residual | MNDR-E-MI-15678 |
| MNDR | hsa-miR-146b-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-15679 |
| MNDR | hsa-miR-146b-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-15680 |
| MNDR | hsa-miR-146b-5p | Tubulovillous adenoma | MNDR-E-MI-15681 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AFAP1-AS1 | Homo sapiens | RR00052624 |
TOP